(PDF) Antiviral Methods and Protocols 2nd Edition by Edwin Yunhao Gong

This is the PDF eBook version for Antiviral Methods and Protocols 2nd Edition by Edwin Yunhao Gong

Table of Contents

Part I: Human Immunodeficiency Virus Type 1 (HIV-1)

1. A Fluorescence-Based High Throughput Screening Assay to Identify HIV-1 Inhibitors

Peggy Geluykens, Koen Van Acker, Johan Vingerhoets, Christel Van den Eynde, Marnix Van Loock, and Géry Dams

2. A Homogeneous Time-Resolved Fluorescence Assay to Identify Inhibitors of HIV-1 Fusion

Liesbet Smeulders, Lieve Bunkens, Inge Vereycken, Koen Van Acker, Pascale Holemans, Emmanuel Gustin, Marnix Van Loock, and Géry Dams

3. Identification of HIV-1 Reverse Transcriptase Inhibitors Using a Scintillation Proximity Assay

Bertrand Van Schoubroeck, Marnix Van Loock, Tania Ivens, Pascale Dehertogh, Dirk Jochmans, and Géry Dams

4. Biochemical Screening Assays to Identify HIV-1 Integrase Inhibitors

Marleen Clynhens, Alexandra Smets, Inge Vereycken, Marnix Van Loock, Reginald Clayton, Geert Meersseman, and Olivia Goethals

5. HIV-1 Genotyping of the Protease-Reverse Transcriptase and Integrase Genes to Detect Mutations that Confer Anti-Retroviral Resistance

Peter Van den Eede, Liesbeth Van Wesenbeeck, Yvan Verlinden, Maxim Feyaerts, Veerle Smits, Ann Verheyen, Leen Vanhooren, Alain Deloof, Jorge Villacian, and Theresa Pattery

Part II: Hepatitis Viruses

6. In Vitro Kinetic Profiling of Hepatitis C Virus NS3 Protease Inhibitors by Progress Curve Analysis

Rumin Zhang and William T. Windsor

7. A Novel Hepatitis C Virus NS5B Polymerase Assayof De Novo Initiated RNA Synthesis Directed from a Heteropolymeric RNA Template

Eric Ferrari and Hsueh-Cheng Huang

8. Selecting and Characterizing Drug-Resistant Hepatitis C Virus Replicon

Inge Vliegen, Leen Delang, and Johan Neyts

9. A Cellular Replicon-Based Phenotyping Assay to Determine Susceptibility of Hepatitis C Virus Clinical Isolates to NS3/4A Protease Inhibitors

Leen Vijgen, Jannick Verbeeck, Barbara Van Kerckhove, Jan Martin Berke, Diana Koletzki, Gregory Fanning, and Oliver Lenz

10. Expression and Purification of Hepatitis C Virus Protease from Clinical Samples

Liesbet van der Helm

11. Surface Plasmon Resonance as a Tool to Select Potent Drug Candidates for Hepatitis C Virus NS5B Polymerase

Erna Cleiren, Benoit Devogelaere, and Katleen Fierens

12. Amplification and Sequencing of the Hepatitis C Virus NS3/4A Protease and the NS5B Polymerase Regions for Genotypic Resistance Detection of Clinical Isolates of Subtypes 1a and 1b

Diana Koletzki, Theresa Pattery, Bart Fevery, Leen Vanhooren, and Lieven J. Stuyver

13. A Southern Blot Assay for Detection of Hepatitis B Virus Covalently Closed Circular DNA from Cell Cultures

Dawei Cai, Hui Nie, Ran Yan, Ju-Tao Guo, Timothy M. Block, and Haitao Guo

14. In Vitro Phenotyping of Recombinant Hepatitis B Virus Containing the Polymerase/Reverse Transcriptase Gene from Clinical Isolates

Yang Liu and Kathryn M. Kitrinos

Part III: Flaviviruses

15. Cell-Based Antiviral Assays for Screening and Profiling Inhibitors Against Dengue Virus

Edwin Yunhao Gong, Marleen Clynhens, Tania Ivens, Pedro Lory, Kenny Simmen, and Guenter Kraus

16. A Duplex Real-Time RT-PCR Assay for Profiling Inhibitors of Four Dengue Serotypes

Edwin Yunhao Gong, Alexandra Smets, Nick Verheyen, Marleen Clynhens, Emmanuel Gustin, Pedro Lory, and Guenter Kraus

17. High Throughput Screening Using Dengue Virus Reporter Genomes

Wolfgang Fischl and Ralf Bartenschlager

18. Fluorimetric and HPLC-Based Dengue Virus Protease Assays Using a FRET Substrate

Christoph Nitsche and Christian D. Klein

19. Expression and Purification of Dengue Virus NS5 Polymerase and Development of a High Throughput Enzymatic Assay for Screening Inhibitors of Dengue Polymerase

Edwin Yunhao Gong, Hannah Kenens, Tania Ivens, Koen Dockx, Katrien Vermeiren, Geneviève Vandercruyssen, Benoit Devogelaere, Pedro Lory, and Guenter Kraus

20. Detection and Quantification of Flavivirus NS5 Methyl-transferase Activities

Siew Pheng Lim, Christophe Bodenreider , and Pei-Yong Shi

21. Testing Antiviral Compounds in a Dengue Mouse Model

Wouter Schul, Andy Yip, and Pei-Yong Shi

22. Construction of Self-Replicating Subgenomic West Nile Virus Replicons for Screening Antiviral Compounds

Sofia L. Alcaraz-Estrada, Erin Donohue Reichert, and Radhakrishnan Padmanabhan

Part IV: Herpes Viruses

23. Methods for Screening and Profiling Inhibitors of Herpes Simplex Viruses

Edwin Yunhao Gong

24. In Vivo Evaluation of Antiviral Efficacy Against Genital Herpes Using Mouse and Guinea Pig Models

Frances Valencia, Ronald L. Veselenak, and Nigel Bourne

25. A Fluorescence-Based High Throughput Screening Assay for Identifying Human Cytomegalovirus Inhibitors

Christel Van den Eynde, Ellen Van Damme, Tania Ivens, and Edwin Yunhao Gong

Part V: Respiratory Viruses

26. A Fluorescence-Based High Throughput Antiviral Compound Screening Assay Against Respiratory Syncytial Virus

Leen Kwanten, Ben De Clerck, and Dirk Roymans

27. Screening and Evaluation of Anti-Respiratory Syncytial Virus Compounds in Cultured Cells

Anna Lundin, Tomas Bergström, and Edward Trybala

28. Evaluation of Antiviral Efficacy Against Human Respiratory Syncytial Virus Using Cotton Rat and Mouse Models

Joke Van den Berg, Leen Kwanten, and Dirk Roymans

29. In Vivo Evaluation of Antiviral Compounds on Respiratory Syncytial Virus Using a Juvenile Vervet Monkey (Chlorocebus pygerythrus) Infection Model

Lieselot Houspie, Hans Stevens, Maina Ngotho, Els Keyaerts, Gabriela Ispas, René Verloes, Marc Van Ranst, and Piet Maes

30. Methods to Determine Mechanism of Action of Anti-Influenza Inhibitors

Angela Luttick, Stephanie Hamilton, and Simon P. Tucker

31. Methods for Evaluation of Antiviral Efficacy Against Influenza Virus Infections in Animal Models

Donald F. Smee and Dale L. Barnard

Part VI: Alphaviruses

32. Development of a High Throughput Antiviral Assay for Screening Inhibitors of Chikungunya Virus and Generation of Drug-Resistant Mutations in Cultured Cells

Edwin Yunhao Gong, Jean-François Bonfanti, Tania Ivens, Marijke Van der Auwera, Barbara Van Kerckhove, and Guenter Kraus

33. A Mouse Model of Chikungunya Virus with Utility in Antiviral Studies

Ashley Dagley and Justin G. Julander